LifeStance, Private Equity Rollup Turned Organic Growth Stock, Targets A Profound Void

ملخص مفصل

LifeStance stock has doubled this year and analysts foresee big time earnings growth. But "the bar is higher" now. The post LifeStance, Private Equity Rollup Turned Organic Growth…

LifeStance Health (LFST) stock has been on a tear this year, doubling in value and outpacing several of its telehealth peers, including Teladoc Health (TDOC), Hims & Hers Health (HIMS) and Doximity (DOCS). The behavioral health services company, built rollup-style through about 100 acquisitions and private-equity backing, is now delivering double-digit revenue growth and clinician adds, with some organic growth…

مطلع المقال، مقتطف من Investor's Business Daily. لقراءة المقال كاملًا، افتحه على موقع الناشر.